LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome. (Q42489900)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Andrew Green

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Georgios Giamas

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

6

Heinz-Josef Lenz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Justin Stebbing

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Aleksandra Filipovic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Tanya Rapoz D'Silva

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

R Charles Coombes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Tingting Wang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Soo-Chin Lee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

English

0 references

publication date

14 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

537-544

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

Endocrine-responsive breast cancer and strategies for combating resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

Systematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

A novel serine phosphorylation site detected in the N-terminal domain of estrogen receptor isolated from human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

Phosphorylation of estrogen receptor-alpha at Ser167 is indicative of longer disease-free and overall survival in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

A review of the ethnic differences in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

Health disparities in breast cancer: biology meets socioeconomic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

HER2 testing in the UK: further update to recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

E-cadherin as a prognostic indicator in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

Protein kinases as targets for cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

Kinases as targets in the treatment of solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1622-Z

10.1007/S10549-011-1622-Z

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671015%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 February 2020

1039436581

0 references

1 reference